Related Experiment Video
Updated: Jan 8, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Prostate MRI Quality Assessment: PI-QUAL and Factors Influencing Image Quality
Abstract:
Since the introduction of Prostate Imaging Reporting and Data System (PI-RADS), prostate MRI has become an essential tool for detecting clinically significant prostate cancer, determining tumor stage, and guiding targeted biopsy. However, variability in image quality across institutions continues to affect diagnostic accuracy. To address this issue, the Prostate Imaging Quality (PI-QUAL) scoring system was developed as a standardized framework for evaluating the quality of prostate MRI. PI-QUAL v1 established the first quality control system for multiparametric MRI (mpMRI) but had limitations, including the inability to assess biparametric MRI (bpMRI) and a strong reliance on biopsy correlation. The updated PI-QUAL v2 simplified technical requirements, incorporated bpMRI assessment, and introduced a reproducible 3-point scale with adjustment rules that balance quality assurance with the diagnostic advantages of mpMRI. Factors influencing image quality include magnetic field strength and susceptibility- and motion-related artifacts. Complementary approaches, such as the Prostate Signal Intensity Homogeneity Score and artificial intelligence-based evaluation tools, have also been proposed. Overall, PI-QUAL v2 enhances reproducibility and broadens clinical applicability, providing a practical framework for ensuring high-quality prostate MRI. Future progress is expected through standardized data collection, structured training, and multidisciplinary collaboration.
Insights
The Prostate Imaging Quality (PI-QUAL) v2 system standardizes prostate MRI quality, improving cancer detection accuracy. This updated framework enhances reproducibility and clinical applicability for high-quality prostate imaging.
Area of Science:
- Radiology
- Medical Imaging
- Oncology
Background:
- Prostate MRI, guided by PI-RADS, is crucial for prostate cancer detection and staging.
- Image quality variations across institutions hinder diagnostic accuracy.
- Previous PI-QUAL v1 had limitations, including inability to assess biparametric MRI (bpMRI).
Purpose of the Study:
- To introduce the updated Prostate Imaging Quality (PI-QUAL) v2 scoring system.
- To address limitations of PI-QUAL v1 and enhance prostate MRI quality assessment.
- To provide a standardized framework for evaluating prostate MRI quality.
Main Methods:
- PI-QUAL v2 simplifies technical requirements and incorporates bpMRI assessment.
- A reproducible 3-point scale with adjustment rules was introduced.
- Factors like magnetic field strength and artifacts were considered.
Main Results:
- PI-QUAL v2 enhances reproducibility in prostate MRI quality assessment.
- The system balances quality assurance with diagnostic advantages of multiparametric MRI (mpMRI).
- It broadens clinical applicability for prostate MRI evaluations.
Conclusions:
- PI-QUAL v2 offers a practical framework for ensuring high-quality prostate MRI.
- Future improvements may involve standardized data collection and multidisciplinary collaboration.
- The system aims to improve diagnostic accuracy in prostate cancer detection.
Related Concept Videos
Imaging Studies IV: Magnetic Resonance Imaging
Magnetic Resonance Imaging

